THE MITOCHONDRIAL-DNA TRANSFER RNA(LEU(UUR)) A-]G((3243)) MUTATION - A CLINICAL AND GENETIC-STUDY

被引:147
作者
HAMMANS, SR [1 ]
SWEENEY, MG [1 ]
HANNA, MG [1 ]
BROCKINGTON, M [1 ]
MORGANHUGHES, JA [1 ]
HARDING, AE [1 ]
机构
[1] UNIV LONDON,INST NEUROL,DEPT CLIN NEUROL,LONDON WC1N 3BG,ENGLAND
基金
英国医学研究理事会;
关键词
MITOCHONDRIAL DNA; MITOCHONDRIAL MYOPATHY; MELAS;
D O I
10.1093/brain/118.3.721
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
The mitochondrial tRNA(Leu(UUR)) A-->G((3243)) mutation was identified in 22 unrelated patients. The probands and their relatives were assessed clinically and by quantitative mitochondrial DNA (mtDNA) analysis. While 10 probands had clinical features consistent with the syndrome of mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes (MELAS), usually associated with this mutation, 12 probands had other phenotypes including other encephalopathies, chronic progressive external ophthalmoplegia (CPEO), myoclonic epilepsy and ragged red fibres (MERRF), myopathy alone and diabetes and deafness. Histochemical analyses of muscle biopsies showed a higher proportion of cytochrome oxidase (COX) negative fibres, but fewer strongly COX reactive fibres, in patients with CPEO compared with those with MELAS. The proportion of mutant mtDNA present in blood was significantly greater in symptomatic than asymptomatic subjects, and was correlated with age in both. This correlation was not observed in patients with the tRNA(Lys) A-->G((8344)) mutation. The proportion of mutant mtDNA A-->G((3243)) in muscle was always greater than that in blood. Significant correlations between proportion of mutant mtDNA in blood and both age of onset of disease and a clinical severity score were observed. However, the proportions of mutant mtDNA in blood in affected and unaffected cases overlapped, preventing use of the genetic-clinical correlation for prognostic or predictive purposes. The presence of intrafamilial clustering of phenotypes and the imperfect relationship between proportion of mutant mtDNA and the presence or absence of disease suggests that other factors may determine the phenotype. To investigate this possibility further, the tRNA(Leu(UUR)) gene was sequenced in 23 probands and six relatives. In 28 patients the sequence was normal apart from the 3243 mutation, but in members of one family there was a homoplasmic T-->C transition at position 3290 which was not found in 140 controls or 50 other patients with mitochondrial myopathy. The family with this transition had high levels of mutant mtDNA A-->G((3243)), With a unique phenotype of predominant skeletal myopathy, suggesting that this second base change in tRNA(Leu(UUR)) may influence the clinical phenotype.
引用
收藏
页码:721 / 734
页数:14
相关论文
共 41 条
[1]  
Anderson S., Bankier A.T., Barrell B.G., De Bruijn M.H., Coulson A.R., Drouin J., Et al., Sequence and organization of the human mitochondrial genome, Nature, 290, pp. 457-465, (1981)
[2]  
Berkovic S.F., Ermann F., Shoubridge E.A., Carpenter S., Robitaille Y., Ermann E., Et al., Mitochondrial dysfunction in multiple symmetrical lipomatosis, Ann Neurol, 29, pp. 566-569, (1991)
[3]  
Bu X.D., Rotter J.I., X chromosome-linked and mitochondrial gene control of Leber hereditary optic neuropathy: Evidence from segregation analysis for dependence on X chromosome inactivation, Proc Natl Acad Sci USA, 88, pp. 8198-8202, (1991)
[4]  
Ciafaloni E., Ricci E., Shanske S., Moraes C.T., Silvestri G., Hirano M., Et al., MELAS: Clinical features, biochemistry, and molecular genetics, Ann Neurol, 31, pp. 391-398, (1992)
[5]  
Dimauro S., Moraes C.T., Mitochondrial encephalomyopathies. [Review, Arch Neurol, 5, pp. 1197-1220, (1993)
[6]  
Goto Y., Nonaka I., Horai S., A mutation in the tRNAlxu(UUR gene associated with the MELAS subgroup of mitochondrial encephalomyopathies [see comments], Nature, 348, pp. 651-653, (1990)
[7]  
Goto Y., Nonaka I., Horai S., A mutation in the tRNAlxu(UUR gene associated with the MELAS subgroup of mitochondrial encephalomyopathies [see comments], Comment In: Nature, 351, (1991)
[8]  
Goto Y., Nonaka I., Horai S., A new mtDNA mutation associated with mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes (MELAS), Biochim Biophys Acta, 1097, pp. 238-240, (1991)
[9]  
Goto Y., Horai S., Matsuoka T., Koga Y., Nihei K., Kobayashi M., Nonaka 1. Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS): A correlative study of the clinical features and mitochondrial DNA mutation, Neurology, 42, pp. 545-550, (1992)
[10]  
Hammans S.R., Morgan-Hughes J.A., Mitochondrial myopathies: Clinical features, investigation, treatment and genetic counselling, Mitochondrial Disorders in Neurology, pp. 49-74, (1994)